Rapid Diagnostic Solutions Driving U.S. Point of Care Lipid Test...

Rapid Diagnostic Solutions Driving U.S. Point of Care Lipid Test Market Growth

Posted 2026-11-10 16:25:01

Polaris Market Research has published its latest research report titled U.S. Point Of Care Lipid Test Market Size, Share, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Application (Hyperlipidemia, Hypertriglyceridemia, Tangier Disease, Hyperlipoproteinemia, Familial Hypercholesterolemia, Others); By Disease Indication (Lipid and Lipoprotein Disorders, Atherosclerosis, Liver and Renal Diseases, Diabetes Mellitus, Others); By End Use (Hospitals, Clinics, Research and Diagnostic Laboratories, Others); Market Forecast, 2025 - 2034. The report examines the U.S. Point Of Care Lipid Test Market, covering its current size, market share, growth prospects, and industry developments. It discusses the factors influencing demand and provides an overview of the changes taking place across the industry.

The study covers the market across the United States. It considers developments in the healthcare industry, changing customer requirements, and factors affecting business activity. The research also looks at the challenges faced by market participants and areas where new business opportunities may emerge.

The report draws on primary and secondary research to assess the market. It considers economic conditions, technological developments, regulatory requirements, and other factors relevant to the industry. The findings offer useful information to businesses, investors, healthcare providers, and other stakeholders assessing the market.

Market Size and Forecast

The U.S. Point Of Care Lipid Test Market was valued at USD 312.04 million in 2024 and is estimated to reach USD 330.03 million in 2025. The market is projected to reach USD 553.25 million by 2034, growing at a CAGR of 5.90% during the forecast period from 2025 to 2034.

The report includes historical data and future estimates to show how the market is expected to develop during the forecast period.

Market Dynamics

Several factors influence the direction of the U.S. Point Of Care Lipid Test Market. The report considers the following areas to understand their effect on market activity:

Supply and Demand: The report examines increasing demand for point-of-care lipid testing solutions due to the rising prevalence of cardiovascular diseases, obesity, and diabetes. The growing need for rapid cholesterol screening and regular lipid monitoring is encouraging healthcare providers to adopt convenient diagnostic solutions across hospitals, clinics, and retail healthcare settings.

Technological Advancements: The study covers advancements in portable lipid analyzers, miniaturized diagnostic devices, and rapid testing technologies. These developments are improving testing convenience, turnaround times, and accessibility while supporting immediate clinical decision-making.

Regulatory and Legal Environment: The report considers regulatory requirements, healthcare policies, reimbursement frameworks, and diagnostic testing standards applicable to the U.S. point-of-care lipid testing industry. FDA requirements and healthcare reimbursement policies influence product development, market access, and adoption among healthcare providers.

Economic Factors: The study takes into account healthcare expenditure, medical technology investments, diagnostic testing costs, and insurance coverage. These factors influence purchasing decisions and the adoption of point-of-care lipid testing solutions across healthcare facilities.

Browse Full Insights:

https://www.polarismarketresearch.com/industry-analysis/us-point-of-care-lipid-test-market

Key Market Trends

The report highlights important developments in the U.S. Point Of Care Lipid Test Market. It examines the growing adoption of rapid diagnostic technologies, increasing awareness of cardiovascular disease prevention, and rising demand for convenient cholesterol monitoring solutions.

The study also considers the expansion of point-of-care testing across hospitals, primary care clinics, retail pharmacies, and other healthcare settings. The increasing availability of portable lipid analyzers is improving access to diagnostic services and supporting faster clinical decisions.

Additionally, technological innovations, digital healthcare integration, and the growing emphasis on preventive healthcare are creating new opportunities for market participants. Healthcare providers are increasingly adopting rapid testing solutions to improve patient convenience and support ongoing management of lipid-related conditions.

Competitive Landscape

The report identifies the major companies operating in the U.S. Point Of Care Lipid Test Market. It provides an overview of their business operations, product offerings, and market presence. The study also covers recent company developments and strategies used to strengthen their positions.

These strategies may include product launches, partnerships, mergers and acquisitions, research and development, and geographical expansion. The report also examines competitive positioning, technological innovation, and challenges that may affect competition.

Some of the key market players include:

Abbott Laboratories
Callegari Srl
F. Hoffmann-La Roche Ltd.
Menarini Group
MiCoBio
Nova Biomedical
SD Biosensor, Inc.
Sinocare Inc.
VivaChek Biotech (Hangzhou) Co., Ltd.

Market Segmentation

The U.S. Point Of Care Lipid Test Market is segmented based on product, application, disease indication, and end use. The report provides estimates for each segment and examines its contribution to the overall market. It also identifies the largest and fastest-growing segments across the different categories.

By Product: